Related Experiment Video
Updated: May 31, 2026

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes
Published on: December 19, 2020
[Quadrivalent meningococcal conjugate vaccine]
1Centre de vaccinations et médecine des voyages, PMU, 1011 Lausanne. Pierre.Landry@hospvd.ch
Abstract:
Meningoccocal meningitis is still a severe disease. In Switzerland the predominant serotypes are serotype B and C, but this could change as other groups predominate elsewhere. The indications for immunizing against meningococcal infections as described in the Swiss recommendations will be reviewed. New quadrivalent vaccines conjugated with a protein and efficient against serogroup ACWY will soon be available in our country. They show a number of advantages in term of type of protection and should simplify the current vaccination schedule while giving a better coverage against various serogroups, especially for travellers, but also for children at risk for complications.
More Related Videos
Related Concept Videos
Bacterial Meningitis
Bacterial Meningitis I: Introduction
Cryptococcal Meningitis
Bacterial Meningitis II: Pathophysiology
Viral Meningitis
Streptococcal Pharyngitis

